Solaris
Alexion, PDL BioPharma settle patent dispute Reuters - USA O) confirmed that its genetic disorder drug Solaris used technology covered by one of PDL BioPharma Inc (PDLI.O) patents and entered into a $25-million ... |
posted by Al @ 1:36 PM
0 Comments
0 Comments:
Post a Comment
<< Home